Resources

PATH has evaluated a variety of reusable neonatal resuscitators, including both bag-and-mask and tube-and-mask designs. This guide is divided into two sections: the first identifies resuscitators that are priced at less than US$30 each, and the second identifies those that are priced at more than $30 each. It also describes the criteria used during the device evaluation, evaluation results for each device, and suggestions for choosing a resuscitator. The guide is available in two formats: one for booklet-style printing and one for onscreen viewing.

The second report in the Roll Back Malaria Progress & Impact Series benchmarks the remarkable progress and momentum that are building toward halting malaria in Africa.

This document identifies key steps and information relevant to the development and implementation of a national procurement policy on safe-injection equipment. The intention is to increase patient and health worker safety, and especially to avoid medical transmission of bloodborne infections such as HIV, hepatitis B, and hepatitis C.

In 2010, the World Health Organization (WHO) issued a new policy to guide activities for controlling tuberculosis (TB) infection. This report provides guidance on advocacy for political and financial support for TB infection control from donors and countries, widespread adoption of the WHO policy, and incorporation of it into national and local policies. The report also addresses advocacy for linkages with civil society organizations in the field to ensure demand for and implementation of the WHO policy to protect health workers, patients, and communities from TB transmission.

This report from the vaccine technologies team at PATH presents results from an economic model that calculates the costs involved in delivering IPV vaccine in Indian immunization clinics according to three strategies: (1) intradermal delivery of reduced volumes of vaccine per dose, (2) use of adjuvants to allow a reduced IPV antigen content per dose, and (3) reduction of the number of doses per IPV immunization schedule. The strategies include delivery by standard technique and with alternative delivery devices.